Manipulation of host cholesterol by Helicobacter pylori for their beneficial ecological niche

BioMedicine (Netherlands)

Volumn 3, Issue 1, 2013, Pages 27-33

  Lai, Chih Ho ^a,b   Hsu, Yuan Man ^b   Wang, Hung Jung ^c   Wang, Wen Ching ^c  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

^c NATIONAL TSING HUA UNIVERSITY   (Taiwan)

Author keywords

Cholesterol; Helicobacter pylori; Lipid rafts; Pathogenesis; Virulence factors

Indexed keywords

CHOLESTEROL;

BACTERIAL INFECTION; BACTERIAL VIRULENCE; CELL MEMBRANE; ECOLOGICAL NICHE; HELICOBACTER PYLORI; HOST PATHOGEN INTERACTION; IMMUNE RESPONSE; IMMUNOREGULATION; LIPID ANALYSIS; LIPID COMPOSITION; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN LIPID INTERACTION; REVIEW; VIRUS INFECTION; VIRUS REPLICATION;

EID: 84875237431     PISSN: 22118020     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomed.2012.12.002     Document Type: Review

References (92)

1. Parsonnet J. Helicobacter pylori. Infect Dis Clin North Am 1998, 12:185-197.
2. Marshall B. Helicobacter pylori: 20 years on. Clin Med 2002, 2:147-152.
3. Blaser M.J. Helicobacter pylori and the pathogenesis of gastroduodenal inflammation. J Infect Dis 1990, 161:626-633.
4. Parsonnet J., Friedman G.D., Vandersteen D.P., Chang Y., Vogelman J.H., Orentreich N., et al. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 1991, 325:1127-1131.
5. Wunder C., Churin Y., Winau F., Warnecke D., Vieth M., Lindner B., et al. Cholesterol glucosylation promotes immune evasion by Helicobacter pylori. Nat Med 2006, 12:1030-1038.
6. Gobert A.P., McGee D.J., Akhtar M., Mendz G.L., Newton J.C., Cheng Y., et al. Helicobacter pylori arginase inhibits nitric oxide production by eukaryotic cells: A strategy for bacterial survival. Proc Natl Acad Sci USA 2001, 98:13844-13849.
7. Zabaleta J., McGee D.J., Zea A.H., Hernandez C.P., Rodriguez P.C., Sierra R.A., et al. Helicobacter pylori arginase inhibits T cell proliferation and reduces the expression of the TCR zeta-chain (CD3zeta). J Immunol 2004, 173:586-593.
8. Lu D.Y., Tang C.H., Chang C.H., Maa M.C., Fang S.H., Hsu Y.M., et al. Helicobacter pylori attenuates lipopolysaccharide-induced nitric oxide production by murine macrophages. Innate Immun 2012, 18:406-417.
9. Monack D.M., Mueller A., Falkow S. Persistent bacterial infections: the interface of the pathogen and the host immune system. Nat Rev Microbiol 2004, 2:747-765.
10. Lai C.H., Kuo C.H., Chen P.Y., Poon S.K., Chang C.S., Wang W.C. Association of antibiotic resistance and higher internalization activity in resistant Helicobacter pylori isolates. J Antimicrob Chemother 2006, 57:466-471.
11. Gebert B., Fischer W., Weiss E., Hoffmann R., Haas R. Helicobacter pylori vacuolating cytotoxin inhibits T lymphocyte activation. Science 2003, 301:1099-1102.
12. Ramarao N., Gray-Owen S.D., Backert S., Meyer T.F. Helicobacter pylori inhibits phagocytosis by professional phagocytes involving type IV secretion components. Mol Microbiol 2000, 37:1389-1404.
13. Mahdavi J., Sonden B., Hurtig M., Olfat F.O., Forsberg L., Roche N., et al. Helicobacter pylori SabA adhesin in persistent infection and chronic inflammation. Science 2002, 297:573-578.
14. Ilver D., Arnqvist A., Ogren J., Frick I.M., Kersulyte D., Incecik E.T., et al. Helicobacter pylori adhesin binding fucosylated histo-blood group antigens revealed by retagging. Science 1998, 279:373-377.
15. Simons K., Ikonen E. Functional rafts in cell membranes. Nature 1997, 387:569-572.
16. Brown D., Waneck G.L. Glycosyl-phosphatidylinositol-anchored membrane proteins. J Am Soc Nephrol 1992, 3:895-906.
17. Brown D.A., London E. Functions of lipid rafts in biological membranes. Annu Rev Cell Dev Biol 1998, 14:111-136.
18. Hooper N.M. Detergent-insoluble glycosphingolipid/cholesterol-rich membrane domains, lipid rafts and caveolae (review). Mol Membr Biol 1999, 16:145-156.
19. Simons K., Toomre D. Lipid rafts and signal transduction. Nat Rev Mol Cell Biol 2000, 1:31-39.
20. Simons M., Kramer E.M., Macchi P., Rathke-Hartlieb S., Trotter J., Nave K.A., et al. Overexpression of the myelin proteolipid protein leads to accumulation of cholesterol and proteolipid protein in endosomes/lysosomes: implications for Pelizaeus-Merzbacher disease. J Cell Biol 2002, 157:327-336.
21. Schnitzer J.E., Oh P., Pinney E., Allard J. Filipin-sensitive caveolae-mediated transport in endothelium: reduced transcytosis, scavenger endocytosis, and capillary permeability of select macromolecules. J Cell Biol 1994, 127:1217-1232.
22. Bini L., Pacini S., Liberatori S., Valensin S., Pellegrini M., Raggiaschi R., et al. Extensive temporally regulated reorganization of the lipid raft proteome following T-cell antigen receptor triggering. Biochem J 2003, 369:301-309.
23. Parton R.G., Joggerst B., Simons K. Regulated internalization of caveolae. J Cell Biol 1994, 127:1199-1215.
24. Wooldridge K.G., Williams P.H., Ketley J.M. Host signal transduction and endocytosis of Campylobacter jejuni. Microb Pathog 1996, 21:299-305.
25. Lafont F., Tran Van Nhieu G., Hanada K., Sansonetti P., van der Goot F.G. Initial steps of Shigella infection depend on the cholesterol/sphingolipid raft-mediated CD44-IpaB interaction. EMBO J 2002, 21:4449-4457.
26. Duncan M.J., Li G., Shin J.S., Carson J.L., Abraham S.N. Bacterial penetration of bladder epithelium through lipid rafts. J Biol Chem 2004, 279:18944-18951.
27. Grassme H., Jendrossek V., Riehle A., von Kurthy G., Berger J., Schwarz H., et al. Host defense against Pseudomonas aeruginosa requires ceramide-rich membrane rafts. Nat Med 2003, 9:322-330.
28. Lin M., Rikihisa Y. Obligatory intracellular parasitism by Ehrlichia chaffeensis and Anaplasma phagocytophilum involves caveolae and glycosylphosphatidylinositol-anchored proteins. Cell Microbiol 2003, 5:809-820.
29. Kowalski M.P., Pier G.B. Localization of cystic fibrosis transmembrane conductance regulator to lipid rafts of epithelial cells is required for Pseudomonas aeruginosa-induced cellular activation. J Immunol 2004, 172:418-425.
30. Lai C.H., Chang Y.C., Du S.Y., Wang H.J., Kuo C.H., Fang S.H., et al. Cholesterol depletion reduces Helicobacter pylori CagA translocation and CagA-induced responses in AGS cells. Infect Immun 2008, 76:3293-3303.
31. Wang M., Hajishengallis G. Lipid raft-dependent uptake, signalling and intracellular fate of Porphyromonas gingivalis in mouse macrophages. Cell Microbiol 2008, 10:2029-2042.
32. Garner M.J., Hayward R.D., Koronakis V. The Salmonella pathogenicity island 1 secretion system directs cellular cholesterol redistribution during mammalian cell entry and intracellular trafficking. Cell Microbiol 2002, 4:153-165.
33. Panchal R.G., Ruthel G., Kenny T.A., Kallstrom G.H., Lane D., Badie S.S., et al. In vivo oligomerization and raft localization of Ebola virus protein VP40 during vesicular budding. Proc Natl Acad Sci USA 2003, 100:15936-15941.
34. Favoreel H.W., Mettenleiter T.C., Nauwynck H.J. Copatching and lipid raft association of different viral glycoproteins expressed on the surfaces of pseudorabies virus-infected cells. J Virol 2004, 78:5279-5287.
35. Chung C.S., Huang C.Y., Chang W. Vaccinia virus penetration requires cholesterol and results in specific viral envelope proteins associated with lipid rafts. J Virol 2005, 79:1623-1634.
36. Bremer C.M., Bung C., Kott N., Hardt M., Glebe D. Hepatitis B virus infection is dependent on cholesterol in the viral envelope. Cell Microbiol 2009, 11:249-260.
37. Pelkmans L., Puntener D., Helenius A. Local actin polymerization and dynamin recruitment in SV40-induced internalization of caveolae. Science 2002, 296:535-539.
38. Naslavsky N., Stein R., Yanai A., Friedlander G., Taraboulos A. Characterization of detergent-insoluble complexes containing the cellular prion protein and its scrapie isoform. J Biol Chem 1997, 272:6324-6331.
39. Manes S., del Real G., Martinez A.C. Pathogens: raft hijackers. Nat Rev Immunol 2003, 3:557-568.
40. Schroeder G.N., Hilbi H. Molecular pathogenesis of Shigella spp.: controlling host cell signaling, invasion, and death by type III secretion. Clin Microbiol Rev 2008, 21:134-156.
41. Hayward R.D., Cain R.J., McGhie E.J., Phillips N., Garner M.J., Koronakis V. Cholesterol binding by the bacterial type III translocon is essential for virulence effector delivery into mammalian cells. Mol Microbiol 2005, 56:590-603.
42. Wolf A.A., Fujinaga Y., Lencer W.I. Uncoupling of the cholera toxin-G(M1) ganglioside receptor complex from endocytosis, retrograde Golgi trafficking, and downstream signal transduction by depletion of membrane cholesterol. J Biol Chem 2002, 277:16249-16256.
43. Abrami L., Liu S., Cosson P., Leppla S.H., van der Goot F.G. Anthrax toxin triggers endocytosis of its receptor via a lipid raft-mediated clathrin-dependent process. J Cell Biol 2003, 160:321-328.
44. Boesze-Battaglia K., Besack D., McKay T., Zekavat A., Otis L., Jordan-Sciutto K., et al. Cholesterol-rich membrane microdomains mediate cell cycle arrest induced by Actinobacillus actinomycetemcomitans cytolethal-distending toxin. Cell Microbiol 2006, 8:823-836.
45. Guerra L., Teter K., Lilley B.N., Stenerlow B., Holmes R.K., Ploegh H.L., et al. Cellular internalization of cytolethal distending toxin: A new end to a known pathway. Cell Microbiol 2005, 7:921-934.
46. Lin C.D., Lai C.K., Lin Y.H., Hsieh J.T., Sing Y.T., Chang Y.C., et al. Cholesterol depletion reduces entry of Campylobacter jejuni cytolethal distending toxin and attenuates intoxication of host cells. Infect Immun 2011, 79:3563-3575.
47. Abrami L., Fivaz M., Glauser P.E., Parton R.G., van der Goot F.G. A pore-forming toxin interacts with a GPI-anchored protein and causes vacuolation of the endoplasmic reticulum. J Cell Biol 1998, 140:525-540.
48. Ricci V., Galmiche A., Doye A., Necchi V., Solcia E., Boquet P. High cell sensitivity to Helicobacter pylori VacA toxin depends on a GPI-anchored protein and is not blocked by inhibition of the clathrin-mediated pathway of endocytosis. Mol Biol Cell 2000, 11:3897-3909.
49. Patel H.K., Willhite D.C., Patel R.M., Ye D., Williams C.L., Torres E.M., et al. Plasma membrane cholesterol modulates cellular vacuolation induced by the Helicobacter pylori vacuolating cytotoxin. Infect Immun 2002, 70:4112-4123.
50. Schraw W., Li Y., McClain M.S., van der Goot F.G., Cover T.L. Association of Helicobacter pylori vacuolating toxin (VacA) with lipid rafts. J Biol Chem 2002, 277:34642-34650.
51. Kuo C.H., Wang W.C. Binding and internalization of Helicobacter pylori VacA via cellular lipid rafts in epithelial cells. Biochem Biophys Res Commun 2003, 303:640-644.
52. Gupta V.R., Patel H.K., Kostolansky S.S., Ballivian R.A., Eichberg J., Blanke S.R. Sphingomyelin functions as a novel receptor for Helicobacter pylori VacA. PLoS Pathog 2008, 4:e1000073.
53. Murata-Kamiya N., Kikuchi K., Hayashi T., Higashi H., Hatakeyama M. Helicobacter pylori exploits host membrane phosphatidylserine for delivery, localization, and pathophysiological action of the CagA oncoprotein. Cell Host Microbe 2010, 7:399-411.
54. Coconnier M.H., Lorrot M., Barbat A., Laboisse C., Servin A.L. Listeriolysin O-induced stimulation of mucin exocytosis in polarized intestinal mucin-secreting cells: evidence for toxin recognition of membrane-associated lipids and subsequent toxin internalization through caveolae. Cell Microbiol 2000, 2:487-504.
55. Zitzer A., Bittman R., Verbicky C.A., Erukulla R.K., Bhakdi S., Weis S., et al. Coupling of cholesterol and cone-shaped lipids in bilayers augments membrane permeabilization by the cholesterol-specific toxins streptolysin O and Vibrio cholerae cytolysin. J Biol Chem 2001, 276:14628-14633.
56. Amieva M.R., El-Omar E.M. Host-bacterial interactions in Helicobacter pylori infection. Gastroenterology 2008, 134:306-323.
57. Xiang Z., Censini S., Bayeli P.F., Telford J.L., Figura N., Rappuoli R., et al. Analysis of expression of CagA and VacA virulence factors in 43 strains of Helicobacter pylori reveals that clinical isolates can be divided into two major types and that CagA is not necessary for expression of the vacuolating cytotoxin. Infect Immun 1995, 63:94-98.
58. Marchetti M., Arico B., Burroni D., Figura N., Rappuoli R., Ghiara P. Development of a mouse model of Helicobacter pylori infection that mimics human disease. Science 1995, 267:1655-1658.
59. Lupetti P., Heuser J.E., Manetti R., Massari P., Lanzavecchia S., Bellon P.L., et al. Oligomeric and subunit structure of the Helicobacter pylori vacuolating cytotoxin. J Cell Biol 1996, 133:801-807.
60. Ilver D., Barone S., Mercati D., Lupetti P., Telford J.L. Helicobacter pylori toxin VacA is transferred to host cells via a novel contact-dependent mechanism. Cell Microbiol 2004, 6:167-174.
61. Gauthier N.C., Monzo P., Kaddai V., Doye A., Ricci V., Boquet P. Helicobacter pylori VacA cytotoxin: A probe for a clathrin-independent and Cdc42-dependent pinocytic pathway routed to late endosomes. Mol Biol Cell 2005, 16:4852-4866.
62. Geisse N.A., Cover T.L., Henderson R.M., Edwardson J.M. Targeting of Helicobacter pylori vacuolating toxin to lipid raft membrane domains analysed by atomic force microscopy. Biochem J 2004, 381:911-917.
63. Nakayama M., Hisatsune J., Yamasaki E., Nishi Y., Wada A., Kurazono H., et al. Clustering of Helicobacter pylori VacA in lipid rafts, mediated by its receptor, receptor-like protein tyrosine phosphatase beta, is required for intoxication in AZ-521 Cells. Infect Immun 2006, 74:6571-6580.
64. Wilkinson S.M., Uhl J.R., Kline B.C., Cockerill F.R. Assessment of invasion frequencies of cultured HEp-2 cells by clinical isolates of Helicobacter pylori using an acridine orange assay. J Clin Pathol 1998, 51:127-133.
65. Ko G.H., Kang S.M., Kim Y.K., Lee J.H., Park C.K., Youn H.S., et al. Invasiveness of Helicobacter pylori into human gastric mucosa. Helicobacter 1999, 4:77-81.
66. Bjorkholm B., Zhukhovitsky V., Lofman C., Hulten K., Enroth H., Block M., et al. Helicobacter pylori entry into human gastric epithelial cells: A potential determinant of virulence, persistence, and treatment failures. Helicobacter 2000, 5:148-154.
67. Allen L.A., Schlesinger L.S., Kang B. Virulent strains of Helicobacter pylori demonstrate delayed phagocytosis and stimulate homotypic phagosome fusion in macrophages. J Exp Med 2000, 191:115-128.
68. Zheng P.Y., Jones N.L. Helicobacter pylori strains expressing the vacuolating cytotoxin interrupt phagosome maturation in macrophages by recruiting and retaining TACO (coronin 1) protein. Cell Microbiol 2003, 5:25-40.
69. Wang Y.H., Gorvel J.P., Chu Y.T., Wu J.J., Lei H.Y. Helicobacter pylori impairs murine dendritic cell responses to infection. PLoS One 2010, 5:e10844.
70. Terebiznik M.R., Raju D., Vazquez C.L., Torbricki K., Kulkarni R., Blanke S.R., et al. Effect of Helicobacter pylori's vacuolating cytotoxin on the autophagy pathway in gastric epithelial cells. Autophagy 2009, 5:370-379.
71. Yahiro K., Satoh M., Nakano M., Hisatsune J., Isomoto H., Sap J., et al. Low-density Lipoprotein Receptor-related Protein-1 (LRP1) Mediates Autophagy and Apoptosis Caused by Helicobacter pylori VacA. J Biol Chem 2012, 287:31104-31115.
72. Amer A.O., Byrne B.G., Swanson M.S. Macrophages rapidly transfer pathogens from lipid raft vacuoles to autophagosomes. Autophagy 2005, 1:53-58.
73. Chu Y.T., Wang Y.H., Wu J.J., Lei H.Y. Invasion and multiplication of Helicobacter pylori in gastric epithelial cells and implications for antibiotic resistance. Infect Immun 2010, 78:4157-4165.
74. Odenbreit S., Puls J., Sedlmaier B., Gerland E., Fischer W., Haas R. Translocation of Helicobacter pylori CagA into gastric epithelial cells by type IV secretion. Science 2000, 287:1497-1500.
75. Segal E.D., Cha J., Lo J., Falkow S., Tompkins L.S. Altered states: involvement of phosphorylated CagA in the induction of host cellular growth changes by Helicobacter pylori. Proc Natl Acad Sci USA 1999, 96:14559-14564.
76. Brandt S., Kwok T., Hartig R., Konig W., Backert S. NF-kappaB activation and potentiation of proinflammatory responses by the Helicobacter pylori CagA protein. Proc Natl Acad Sci USA 2005, 102:9300-9305.
77. Saadat I., Higashi H., Obuse C., Umeda M., Murata-Kamiya N., Saito Y., et al. Helicobacter pylori CagA targets PAR1/MARK kinase to disrupt epithelial cell polarity. Nature 2007, 447:330-333.
78. Higashi H., Yokoyama K., Fujii Y., Ren S., Yuasa H., Saadat I., et al. EPIYA motif is a membrane-targeting signal of Helicobacter pylori virulence factor CagA in mammalian cells. J Biol Chem 2005, 280:23130-23137.
79. Lai C.H., Wang H.J., Chang Y.C., Hsieh W.C., Lin H.J., Tang C.H., et al. Helicobacter pylori CagA-mediated IL-8 induction in gastric epithelial cells is cholesterol-dependent and requires the C-terminal tyrosine phosphorylation-containing domain. FEMS Microbiol Lett 2011, 323:155-163.
80. Zeaiter Z., Cohen D., Musch A., Bagnoli F., Covacci A., Stein M. Analysis of detergent-resistant membranes of Helicobacter pylori infected gastric adenocarcinoma cells reveals a role for MARK2/Par1b in CagA-mediated disruption of cellular polarity. Cell Microbiol 2008, 10:781-794.
81. Viala J., Chaput C., Boneca I.G., Cardona A., Girardin S.E., Moran A.P., et al. Nod1 responds to peptidoglycan delivered by the Helicobacter pylori cag pathogenicity island. Nat Immunol 2004, 5:1166-1174.
82. Kwok T., Zabler D., Urman S., Rohde M., Hartig R., Wessler S., et al. Helicobacter exploits integrin for type IV secretion and kinase activation. Nature 2007, 449:862-866.
83. Hutton M.L., Kaparakis-Liaskos M., Turner L., Cardona A., Kwok T., Ferrero R.L. Helicobacter pylori exploits cholesterol-rich microdomains for induction of NF-kappaB-dependent responses and peptidoglycan delivery in epithelial cells. Infect Immun 2010, 78:4523-4531.
84. Lebrun A.H., Wunder C., Hildebrand J., Churin Y., Zahringer U., Lindner B., et al. Cloning of a cholesterol-alpha-glucosyltransferase from Helicobacter pylori. J Biol Chem 2006, 281:27765-27772.
85. Beigier-Bompadre M., Moos V., Belogolova E., Allers K., Schneider T., Churin Y., et al. Modulation of the CD4+ T-cell response by Helicobacter pylori depends on known virulence factors and bacterial cholesterol and cholesterol alpha-glucoside content. J Infect Dis 2011, 204:1339-1348.
86. Wang H.J., Cheng W.C., Cheng H.H., Lai C.H., Wang W.C. Helicobacter pylori cholesteryl glucosides interfere with host membrane phase and affect type IV secretion system function during infection in AGS cells. Mol Microbiol 2012, 83:67-84.
87. Aderem A., Ulevitch R.J. Toll-like receptors in the induction of the innate immune response. Nature 2000, 406:782-787.
88. Triantafilou M., Gamper F.G., Lepper P.M., Mouratis M.A., Schumann C., Harokopakis E., et al. Lipopolysaccharides from atherosclerosis-associated bacteria antagonize TLR4, induce formation of TLR2/1/CD36 complexes in lipid rafts and trigger TLR2-induced inflammatory responses in human vascular endothelial cells. Cell Microbiol 2007, 9:2030-2039.
89. Yokota S., Okabayashi T., Rehli M., Fujii N., Amano K. Helicobacter pylori lipopolysaccharides upregulate toll-like receptor 4 expression and proliferation of gastric epithelial cells via the MEK1/2-ERK1/2 mitogen-activated protein kinase pathway. Infect Immun 2010, 78:468-476.
90. Basu S., Pathak S.K., Chatterjee G., Pathak S., Basu J., Kundu M. Helicobacter pylori protein HP0175 transactivates epidermal growth factor receptor through TLR4 in gastric epithelial cells. J Biol Chem 2008, 283:32369-32376.
91. Lu D.Y., Chen H.C., Yang M.S., Hsu Y.M., Lin H.J., Tang C.H., et al. Ceramide and Toll-like receptor 4 are mobilized into membrane rafts in response to Helicobacter pylori infection in gastric epithelial cells. Infect Immun 2012, 80:1823-1833.
92. Adamson C.S., Freed E.O. Novel approaches to inhibiting HIV-1 replication. Antiviral Res 2010, 85:119-141.